The experts wait for a reduction in the cases of cancer from 2025
” ESMO congress, the major scientific and medical event on the cancer, will be celebrated in Madrid from September 8 to September 12 “
More than 23.000 experts of 130 countries will take part in the congress of the European Company of Medical Oncology, which will be celebrated in Madrid (Spain) from September 8 to September 12. For these summons there have been received a total of 3.260 scientific studies, 150 of Spanish them. Thanks to the campaigns of prevention, the change of habits and the early detection, the specialists hope that the incident of the disease diminishes in eight years.
” Until 2025 the cases of cancer will be increased, due to the increase of the life expectancy and the consequent aging of the population “, has indicated today in a press conference Josep Tabernero, chief of the service of Medical Oncology of the Hospital Vall d’Hebron of Barcelona and elect president of the European Company of Medical Oncology (ESMO).
Nevertheless, Bartender has emphasized that from the above mentioned date ” this trend will start sending, thanks to the campaigns of prevention that already are carried out, at the rate of habits and the early methods of detection as the screening
The new president has advanced the principal contents that will be approached in ESMO congress, which is celebrated in Madrid between 8 and on September 12 and which is considered to be the major scientific and medical event on the cancer.
Some of the topics on that one will penetrate into this event are the new scoreboards to diagnose and to evaluate the response to the treatment of every patient, the immunotherapies based on the defensive system of the organism against the tumor, the combinations of already known medicaments and of others in process of investigation, the paper of the regulatory agencies and the price of the medicaments.
Bartender has emphasized the fact that in this occasion the congress is celebrated in collaboration with the European Association of Investigation in Cancer (EACR). ” The advance in new treatments oncológicos cannot be carried out without the detailed molecular knowledge that comes to us across the investigators who do basic science “, has been added by it.
For your part Miguel Martin, president of the Spanish Company of Medical Oncology (SEOM) and host of the event, has stood out the contained scientific high place of the congress, ” since 3.260 studies have been received, 150 of Spanish them “.
According to Martin, there are waited very interesting results of several studies that can change the clinical practice into diverse tumors. ” In the past, the communications of these works were realized almost exclusively in medical congresses celebrated in The United States, but in the last years ESMO’s congress is chosen increasingly for the first presentations of new information, which is a reflection of the increasing prestige that this event and the medical European oncology are acquiring “, has underlined.
On the other hand, Andrés Cervantes, chief of Section of the Service of Medical Oncology of the University Hospital of Valencia and the director of ESMO Educational Committee, has indicated that the cancer of lung will be one of the tumors in which more scientific innovations are waited in this congress.
” Also we will know advances in cancer of kidney and bladder, tumors of the uterine neck, new molecules in cancer of breast and positive results so much with therapies directed as immunotherapies “, has been commented by it.
In the press conference, also it has controlled Pilar Garrido, boss of the Unit of Thoracic Tumors of the University Hospital Ramon and Cajal, who has insisted in ” the importance of the collaboration between clinical and basic investigators “. Of this form, ” the interaction is promoted and there is favored the mutual learning that they are engines of the knowledge “.
The specialist is responsible also for the committee that will evaluate the studies on cancer of lung of cells not metastásico and other thoracic tumors. Neat it has indicated that the benefits that will be known in ESMO 2017 do not limit themselves to the advanced disease, ” but there is waited proved also in the first line, which will allow us to modify the standard in the treatment of some types of cancer of lung “.
In fact, ” in this event they are going to present results that can change the welfare practice into different cancers, for what has foreseen three presidential meetings, besides multiple meetings directed concrete tumors “, he has noticed.
Neat she is in addition one of the European leaders of the project Women for Oncology, an international initiative that approaches from several points of view the scanty representation of the women in the positions of responsibility of the world oncology, as headquarters of service in the hospitals, cooperative groups or committees of clinical tests. (Source: SINC)